In vitro-generated stem cell leukaemia showing altered cell cycle progression with distinct signalling of the tyrosine-phosphorylated rasGAP-associated p62(dok) protein

Journal of Pathology

Volumn 192, Issue 3, 2000, Pages 363-372

  Huss, Ralf ^a,e   Weissinger, Eva M ^b   Lange, Claudia ^b   Gatsios, Petros ^c   Eissner, Günther ^d   Kolb, Hans Jochem ^b,d   Diebold, Joachim ^a   Heinrich, Peter C ^c   Graeve, Lutz ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e Institute of Pathology   (Germany)

Author keywords

Haematopoietic stem cell leukaemia; MHC class II; p62(dok)

Indexed keywords

1 NAPHTHYL ACETATE ESTERASE; CD34 ANTIGEN; CYCLIN B; CYCLIN D3; DOCKING PROTEIN; INTERLEUKIN 6; MYELOPEROXIDASE; PROTEIN BCL 2; PROTEIN KINASE; PROTEIN P27; PROTEIN P62; RAS PROTEIN; STAT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL CLONE; CELL CYCLE PHASE; CELL LINE; CELL STRUCTURE; CELL TRANSFORMATION; FIBROBLAST; GENETIC TRANSFECTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKEMIA; MALIGNANT TRANSFORMATION; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ACUTE DISEASE; APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL COMMUNICATION; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; HLA-DR ANTIGENS; HUMANS; IN SITU NICK-END LABELING; INTERLEUKIN-6; LEUKEMIA; RAS GTPASE-ACTIVATING PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0033646180     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH716>3.0.CO;2-N     Document Type: Article

References (42)

1. Linkage of proliferation and maturational abnormalities in chronic myelogenous leukemia and relevance to treatments
2. Haematopoietic progenitor cells transfected with a differentiation antigen show cellular transformation and tumor growth in mice
3. Differentiation of canine bone marrow cells with characteristics from an adherent stromal cell precursor
4. Contact- and growth factor-dependent survival in a canine marrow-derived stromal cell line
5. Cell cycle checkpoint is bypassed by human papillomavirus oncogenes
6. p62dok: A constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells
7. Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, dok
8. HLA-DR triggered inhibition of hematopoiesis involves fas/fas-ligand interactions and is prevented by c-kit ligand
9. Interferon-alpha and dexamethasone inhibit adhesion of T-cells to endothelial cells and synovial cells
10. Mechanisms of inhibition of Raf-1 by protein kinase A
11. Inhibition of the raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl transformed cells
12. A rapid micropreparation technique of DNA-binding proteins from limiting numbers of mammalian cells
13. Oncostatin M differentially regulates tissue inhibitors of metalloproteinases TIMP-1 and TIMP-3 gene expression in human synovial lining cells
14. The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family
15. Differential activation of acute phase response factor/STAT3 and STAT1 via cytoplasmic domain of the interleukin 6 signal transducer gp130. I. Definition of a novel phosphotyrosine motif mediated STAT1 activation
16. Single-step purification and structural characterization of human interleukin-6 produced in Escherichia coli from T7 RNA polymerase expression vector
17. Soluble human interleukin-6 receptor. Expression in insect cells, purification and characterization
18. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
19. Analysis of HLA-D region-associated molecules with monoclonal antibodies
20. Quiescence of CD34-negative haematopoietic stem cells is mediated by down regulation of cyclin B and no STAT activation
21. Regulation of p34 cdc2 protein kinase during mitosis
22. Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle
23. Role of cyclin-dependent kinase inhibitors in the development of cancer
24. P27/Kip1 mutation found in breast cancer
25. Alterations of the p27 KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma
26. Intracellular interleukin-6 mediates platelet-derived growth factor-induced proliferation of nontransformed cells
27. Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit
28. Stem cell factor induced expression of p27 kip-1 during hematopoietic differentiation
29. A 62-kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populations
30. c-kit ligand stimulates tyrosine phosphorylation of a similar pattern to phosphotyrosyl proteins in primary primitive normal hematopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemia
31. A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants
32. The N-terminal region of GAP regulates cytoskeletal structure and cell adhesion
33. Specific changes of rasGTPase-activating protein (GAP) and a GAP-associated p62 protein during calcium-induced keratinocyte differentiation
34. Phosphorylation of GAP and PAP-associated proteins by transforming and mitogenic tyrosine kinases
35. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products
36. Cell cycle checkpoints, genomic integrity, and cancer
37. The role of class II molecules in human B cell activation. Association with phosphatidyl inositol turnover, protein tyrosine phosphorylation and proliferation
38. Induction of tyrosine phosphorylation in human MHC class II-positive antigen-presenting cells by stimulation with contact sensitizers
39. HLA-class II-induced translocation of PKC alpha and PKC beta II isoforms is abrogated following truncation of DR beta cytoplasmic domains
40. TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression
41. The SIF binding elements confers sis/PDGF inducibility onto the c-fos promotor